The Effect of EGF-Pathway Targeted Immunization (EGF PTI) on STAT3 and Cancer Stem Cells in EGFR Mutant NSCLC Cells

Por: Servat, JC, Vila, MAM, Bertran-Alamillo, J, Garcia, S, Karachaliou, N, D'Hondt, E and Rosell, R

---

Publicada: 1 ene 2017

---

---

Filiaciones:
Servat, JC:
 Ior Quiron Dexeus Univ Inst, Pangaea Biotech Sl, Lab Cellular & Mol Biol, Barcelona, Spain

Vila, MAM:
 Ior Quiron Dexeus Univ Inst, Pangaea Biotech Sl, Lab Cellular & Mol Biol, Barcelona, Spain

Bertran-Alamillo, J:
 Ior Quiron Dexeus Univ Inst, Pangaea Biotech Sl, Lab Cellular & Mol Biol, Barcelona, Spain

Garcia, S:
 Inst Quim Sarria, Barcelona, Spain

Karachaliou, N:
 Hosp Univ Quiron Dexeus, Inst Oncol Dr Rosell IOR, Barcelona, Spain

D'Hondt, E:
 R&d & Regulatory Bioven Europe, Aberdeen, Scotland

:
 Catalan Inst Oncol, Lab Cellular & Mol Biol, Badalona, Spain

 Inst Invest Ciencies Germans Trias & Pujol, Badalona, Spain